Baltimore, MD, United States of America

Farideh M Beigi

USPTO Granted Patents = 1 



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Farideh M Beigi

Introduction

Farideh M Beigi is a prominent inventor based in Baltimore, MD, known for her significant contributions to the field of pharmacology. She has made strides in developing compounds that target specific receptors in the body, which can lead to advancements in treating various medical conditions.

Latest Patents

Farideh M Beigi holds a patent concerning the discovery of (R,R)- and (R,S)-fenoterol analogues. These analogues are highly effective at binding to β2-adrenergic receptors. The patent includes exemplary chemical structures for these analogues, as well as pharmaceutical compositions that incorporate the disclosed (R,R)-fenoterol and fenoterol analogues. Furthermore, it outlines methods for using these compounds and compositions in the treatment of cardiac disorders, such as congestive heart failure, and pulmonary disorders, including asthma and chronic obstructive pulmonary disease. She has 1 patent to her name.

Career Highlights

Farideh M Beigi is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to contribute to significant advancements in medical research and drug development.

Collaborations

Some of her notable coworkers include Irving William Wainer and Weizhong Zhu, who have collaborated with her on various research projects.

Conclusion

Farideh M Beigi's innovative work in pharmacology and her patent on fenoterol analogues highlight her contributions to medical science. Her efforts continue to pave the way for new treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…